Skip to main content
Contact Us and FAQs
A-
A+
EN
繁
简
About the Academy
Messages from Academy President and Officers
History and Milestones
Governance
Our Objectives
Academy Colleges
Recognised Specialties and Fellows Register
Policy Statements, Corporate and Medical Publications
Academy Identity
Corporate Video
Academy Building
Academy Shop
Academy Fellows
Fellows' Handbook
Fellowship and Subscription
Specialist Registration
CME / CPD Principles and Guidelines
Accredited CME / CPD Activities
iCMECPD
Honours, Awards and Prizes
Fellow Benefits and Services
Nurturing Medical Leaders
Update Contact Details
Specialist Trainees
Information Pack
Academy e-Portfolio
Awards and Prizes
Extended Benefits and Services
Becoming an Academy Fellow
Career Advancement Support
Events and Services
Flagship and Annual Events
Events
Event Management Services
Venue Hire
Publication Services
Catering Services
Academy Lounge and Library
Professional Services
Our Initiatives
Advancement of Medical and Dental Education
Local and Global Collaborations
Education Office
eHKAM
SZ-HK Medical Specialist Training Centre
Academic Publications and Research
Medical Credentialling, Professionalism and Ethics
Promotion of Doctors’ Well-being
HKAM AI Portal
Media Corner
A-
A+
繁
简
Contact Us and FAQs
Follow Us
Primary tabs
•••
View
(active tab)
EDM Export
Auto Translate
Announcements from Department of Health
Breadcrumb
Home
Latest News
Announcements from Department of Health
Announcements from Department of Health
07 . 05 . 2024
Please note the following announcements from Department of Health:
A new set of growth chart - The Hong Kong 2020 Growth References (HK2020) and upcoming seminar
CHMP recommended new contraindications on the co-administration of Reyataz (Atazanavir) with encorafenib and ivosidenib, and with carbamazepine, phenobarbital, and phenytoin